Transglutaminases (EC 2.3.2.13) catalyze the cross-linking and amine incorporation of proteins. They have been classiˆed into at leastˆve types (plasma-, tissue-keratinocyte-, epidermis-, and prostatetypes), and are involved in various biological phenomena such as blood clotting, wound healing, keratinization of epidermis, apoptosis, cell diŠerenti-ation, and cell signaling (for reviews, see Refs. [1] [2] [3] . Study of inhibitors of transglutaminase is important to understand the physiological roles and reaction mechanism of transglutaminase, and to develop pharmacological agents for diseases assumed to be related to over-action of transglutaminases. We reported previously that Streptomyces lavendulae Y-200, isolated from soil, produced a substance that inhibited transglutaminases.
4) It appeared to be a melanin substance with a high molecular mass and dark-brown color. In this study, we examined whether melanin substance inhibits transglutaminases, using synthetic tyrosine melanin.
Guinea pig liver transglutaminase (tissue-type transglutaminase) was puriˆed on an immunoadsorbent column with a monoclonal antibody as described previously. 5) Recombinant human keratinocyte-and mouse epidermis-transgulutaminases were a gift from Drs. K. Hitomi and M. Maki (Nagoya University, Japan). A microbial transglutaminase from Streptoverticillium was a gift from Ajinomoto Co., Inc. (Tokyo, Japan). The silkworm hemolymph was collected fromˆfth instar larvae and melanized by incubation at 259 C for 1 h and at 609 C for 30 min. The melanized sample was chilled and centrifuged. The supernatant was used as the melanized hemolymph. Melanin precursors, 5,6-dihydroxyindole-2-carboxylic acid (DHICA) 6) and 5-S-cysteinyldopa (5-S-CD), 7) were prepared by reported methods. Other materials were obtained commercially from the sources indicated: N-Carbobenzoxy-Lglutaminylglycine (Peptide Institute Inc., Osaka, Japan); [2,5- 3 H] histamine (Amersham International Plc., Amersham, UK); synthetic tyrosine melanin and as-casein (Sigma, St. Louis, MO); human Factor XIII, plasma-type protransglutaminase (Hexist Japan, Tokyo, Japan).
The transglutaminase activity was measured by two methods: the colorimetric method 8) using N-carbobenzoxy-L-glutaminylglycine and hydroxylamine as the substrates with some modiˆcation, 4) and thê lter paper method 9) using dimethyl casein and [2,5-3 H]histamine as the substrates. 4) Factor XIII and recombinant epidermis transglutaminase were activated by limited proteolysis with thrombin and dispase, respectively. as-Casein was cross-linked by transglutaminase and the products were monitored by SDS-PAGE as described previously.
4) The inhibition rate (z) of inhibitory substances was calculated by using the equation (A-I) W A×100, in which A is the enzyme activity measured in the absence of the inhibitory substance and I is the activity measured in the presence of the inhibitory substance.
Synthetic tyrosine melanin inhibited guinea pig liver transglutaminase dose-dependently in the colorimetric assay system (Fig. 1) . Fifty percent inhibition was caused at the concentration of 25 mg W ml (0.5 mM, based on the tentative molecular mass (50,000) measured by the gelˆltration on Toyopearl Various amounts of synthetic melanin were added to the assay mixture. The transglutaminase activity was assayed by the colorimetric method. The reaction conditions were the same as those described previously 4) except that as-casein was used as substrate instead of b-casein. Reactions were stopped at intervals by mixing portions of the reaction mixture with SDS-PAGE sample buŠer. Migration was from top to bottom. Lane M; molecular mass marker proteins, the arrow of monomer; bands of monomer ascasein, the arrow of polymer; bands of cross-linked as-casein.
HW-65F column). We tested the inhibitory action of the synthetic tyrosine melanin in diŠerent transglutaminase assay systems such as the incorporation of 3 H-labeled histamine into protein and the crosslinking of proteins. The synthetic tyrosine melanin inhibited both the incorporation of the labeled histamine into dimethyl casein (Fig. 2 ) and the intermolecular cross-linking of as-casein (Fig. 3) catalyzed by guinea pig liver transglutaminase. Transglutaminases other than tissue-type liver transglutaminase, such as plasma-, keratinocyte-, and epidermis-types of transglutaminases and calcium-independent microbial transglutaminase, were also inhibited by the synthetic tyrosine melanin with similar dose-dependency proˆles (Fig. 2) . Against all types of transglutaminase, 50z inhibition occurred with 0.5-0.8 mg W ml of the melanin. The inhibition of the calcium-independent microbial transglutaminase was not aŠected signiˆcantly by the presence of calcium. Lineweaver-Burk plot analysis done on guinea pig liver transglutaminase in the presence and absence of the synthetic tyrosine melanin indicated that the melanin inhibited the enzyme in a competitive-type inhibitory manner with respect to glutamine substrate (Fig. 4) . Dixon plot analysis also showed the competitive-type inhibition with the glutamine substrate and apparent Ki of 0.4 mM.
The melanized hemolymph of the silkworm inhibited guinea pig liver transglutaminase dose-dependently (data not shown). Fifty percent inhibition was caused by adding 10 ml of the melanized hemolymph to the colorimetric assay system (total volume was 150 ml). The melanin solutions which were prepared from melanin precursor solutions (each of DHICA and 5-S-CD was dissolved in 25 mM Tris-HCl, pH 7.5, to 5 mM, incubated at 609 C for 32 h, and centrifuged to remove insoluble materials) also inhibited guinea pig liver transglutaminase: the solutions (15 ml each) from DHICA and 5-S-CD caused 45 and 30z inhibition, respectively in theˆlter paper assay (total volume was 75 ml). The results described here suggested that melanin substances generally inhibit transglutaminases. Animal transglutaminases require calcium ions for their activity, while the microbial transglutaminase used here works in the absence of calcium ions. Thê nding that the synthetic tyrosine melanin inhibited both the calcium-dependent and calcium-independent transglutaminases (Fig. 2) suggested that the inhibition is not caused by a possible chelation of calcium ions by melanin substances. Further experimental analyses are needed to clarify the mechanism of the transglutaminase inhibition by melanin substances.
The inhibitory actions of the synthetic tyrosine melanin were very similar to those of the high molecular mass inhibitory melanin-like substance produced by Streptomyces lavendulae Y-200. 4) With both inhibitory substances, the concentrations required forˆfty percent inhibition in the two assay methods used here were very diŠerent: a higher concentration was required in theˆlter paper method. One possible reason for this is that the glutamine substrate (dimethylcasein) used in theˆlter paper method may have a higher a‹nity for transglutaminase than that ( N-carbobenzoxy-Lglutaminylglycine) used in the colorimetric method.
In animal skin, melanin is synthesized in the melanosomes of melanocytes and the melanosomes are transferred into keratinocytes. Then some melanosomes are degraded and melanin is released in the keratinocytes. 10) In the diŠerentiated keratinocytes, several structural proteins such as loricrin, involucrin, and elaˆn are cross-linked by transglutaminases to form the corniˆed cell envelope.
11)
The inhibitory function of melanin might contribute to the repressive regulation of these cross-linking reactions in the keratinocytes.
